u/No_Yogurtcloset7776

Theyre trolling the traditional way things are done on instagram. Its just funny.

Hi everyone, I've been listening to and reading a lot of books related to Investing, or investment adjacent books. This book mentions opendoor by name actually, and discusses how technology plays a role in retail and how its being applied to real estate. I think it was originally published in 2019, before opendoor went public. It just mentioned opendoor in introduction but the topic is obviously directly related. I have a long commute so much of my "reading" are audiobooks and just listening. Im not done yet but its pretty interesting.

Skip tbe circus. Skip straight to sold. Opendoor.com

Hi everyone,

So Talphera (previously AcelRx) is currently testing Nafamostat, a regional anticoagulant medication used during CRRT, whereas no medication has this ability (citrate is not FDA approved for CRRT). They need 70 patients total, and the last quarter they announced about 61% patients signed up. They did push the date from finishing trial around july/August to end of year (with FDA approval now in early next year).

There was a ton of insider purchasing lately (shown above) despite them having the ability to grant shares. Yes there was some dilution last year, but they now have enough cash to last until the end of the trial.

Nafamostat/Niyad has been used in Japan for about 4 decades, and is actually preferred by doctors there (and South Korea for a shorter amount of time) over Heparin. So the medication itself has been shown to be effective, which to me reduces the risk a bit.

The FDA gave Nafamostat a breakthrough device Designation status so that once the trial is done the approval period is sped up. Nafamostat also already has a billing code for it (XY0YX37), by CMS, which means it can be billed to insurance when its approved, a process that usually takes 6 months to a year.

Enter CorMedix deal, who now owns 19% of TLPH (CorMedix only holding) with the option to buy 100% of the company within 60 days of trial completion. So TLPH is a buyout candidate. I think (and analysts agree) that this company is worth at least $3-$4 a share, once trial is completed. So far they've had good results with it, just recruiting is hard due to a limited population of those who are heparin resistant or at risk of bleeding too much on heparin. Even if it gets de-listed, it wont matter if they're bought out.

I'm in for 3700 shares at $0.96 average. Just want to hear your thoughts or shit all over my thesis.

Thought this was interesting. I haven't pledged anything towards it. But if it's a scam, its genius. If its real, then it's still kinda smart. Buying a company for next to nothing. Using GreenBay Packers ownership model.

I have not pledged anything for it. Just curious about thoughts (if its a scam, legit) and I didn't know where else to post it.

Idk if its legit or not. NFA. proposed pledge (no money sent yet). The profits would be proportional to the amount you put in, like any shares. BUT, one person = one vote, not dependent on how many shares.

Just figured if they dont know already, reddit should know. There's over $300 Million pledged at this point.

https://www.aol.com/articles/man-posted-joke-buying-spirit-115135142.html

DISCLAIMER: idk if this is legit or not. Not financial advice. Do your DD